Richard Van Etten in front of new cancer center building

Oct 18, 2023

Leading the way in cancer care

When it opens in summer 2024, the new UCI Health Chao Family Comprehensive Cancer Center and Ambulatory Care building in Irvine "will be the ultimate in state-of-the art cancer care on the West Coast,” said Dr. Richard A. Van Etten after a recent tour of the construction site.
Nicholas R. Conway, MD, and 888 Betty L. Sha Foundation Infusion Terrace at UCI Health — Irvine.

Aug 01, 2023

$2 million gift from the Nicholas R. Conway, DO, and Betty Sha Family names infusion center terrace at UCI Health ― Irvine

UCI Health is pleased to announce a generous $2 million donation from the Nicholas R. Conway, DO, and Betty Sha Family, which will significantly contribute to the development of the $1.3 billion UCI Health – Irvine medical campus. In acknowledgment of this gift, the outdoor infusion center terrace at the new Chao Family Comprehensive Cancer Center and Ambulatory Care building will proudly carry the name of the Nicholas R. Conway, DO, and 888 Betty L. Sha Foundation Infusion Terrace.
Doctor looking at slides

Jul 31, 2023

UC Irvine receives record $653 million in research funding for fiscal 2022-23

The Chao Family Comprehensive Cancer Center received $106 million for basic, translational and clinical studies in fiscal 2022-23, 28 percent more than last year.

NAPBC Logo

Jul 26, 2023

UCI Health Breast Center earns national accreditation

The National Accreditation Program for Breast Centers (NAPBC), a quality standards program administered by the American College of Surgeons, has granted accredited status to the UCI Health Breast Center. The UCI Health Breast Center is part of the Chao Family Comprehensive Cancer Center, the only National Cancer Institute-designated comprehensive center based in Orange County. This NCI designation reflects the deep longstanding commitment the university and health system make to advancing scientific understanding of the causes and prevention of cancer and translational and clinical research to improve the standards of cancer care.
Person running towards finish line at Anti-Cancer Challenge

Jun 13, 2023

UCI Anti-Cancer Challenge hits milestone in search for next breakthrough cancer treatments

Through the unwavering support of dedicated participants, donors and supporters who collectively raised more than $1 million in 2022, the UCI Anti-Cancer Challenge has awarded grants to 28 pilot projects and early phase clinical trials, reaching a remarkable milestone of 100 funded projects since 2017. These projects are poised to revolutionize the future of cancer diagnosis, treatment and cures.
Daniela Bota in Lab

Jun 07, 2023

The Audley Fund of the Philadelphia Foundation backs Dr. Daniela Bota's search for a glioblastoma cure

UCI Health and neuro-oncologist Dr. Daniela A. Bota, MD are pleased to receive a third consecutive grant from The Audley Fund of the Philadelphia Foundation to support research to find a cure for brain cancer, especially glioblastoma.
Two individuals posing with their medals

Mar 15, 2023

UCI Anti-Cancer Challenge returns on Oct. 7 to raise funds for life-saving research

On Saturday, Oct. 7, 2023, UCI Anti-Cancer Challenge participants and supporters will gather at UCI Aldrich Park to enjoy festivities dedicated to raising funds and awareness for critical cancer research. Individuals who register to ride, run, walk or volunteer can get involved in person or virtually.
Headshot of Peter Kaiser

Aug 10, 2022 | UCI School of Medicine

New UCI-led study reveals computation-guided approach to suppressing cancer tumor growth

A new study, led by researchers from the University of California, Irvine and the University of California, San Diego, reveals a new computation-guided approach to identify small molecules that can restore aspects of wild-type p53 tumor suppression function to mutated p53, which play an important role in many human cancers. This approach was successful both in vitro and in vivo. This strategy can increase chemical diversity of p53 corrector molecules for clinical development.
From left: Bridget Fortin (Graduate student and co-first author), Sung Kook Chun, PhD (Postdoctoral fellow and co-first author), Selma Masri, PhD, (Principal investigator and corresponding author), and Rachel Fellows, PhD (Postdoctoral fellow and co-first author), all from the UCI School of Medicine Department of Biological Chemistry.

Aug 10, 2022 | UCI School of Medicine

New UCI-led research reveals the circadian clock influences cell growth, metabolism and tumor progression

In a new University of California, Irvine-led study, researchers define how the circadian clock influences cell growth, metabolism and tumor progression. Their research also reveals how disruption of the circadian clock impacts genome stability and mutations that can further drive critical tumor promoting pathways in the intestine.
cancer ribbon

Jan 26, 2022

UCI and CSU Fullerton partner to advance cancer health disparities research with a focus on diversity and inclusion

With a grant of more than $1.1 million from the National Cancer Institute (NCI), the UCI Chao Family Comprehensive Cancer Center (CFCCC) and California State University, Fullerton (CSUF) have established a collaborative partnership focused on addressing cancer disparities of the highest need in Orange County.